Oncology
A recent study confirms that 5-FU exerts part of its anti-cancer effects through inhibiting the growth of F. nucleatum, the commensal associated with colorectal cancer progression.
The findings of a recent study suggest that DNA damage-inducing microbial metabolites such as indolimines play a role in the development of colorectal cancer.
The findings of a new research may help to develop improved diagnostic or treatment approaches for pancreatic cancer.
New studies provide evidence that there may be fungi within tumors and could also help to diagnose certain types of cancer or predicting their course.
A gut microbial metabolite called trimethylamine N-oxide, or TMAO, could improve immunotherapy success in pancreatic cancer.
Ghaith Bakdash described how Microbiotica discovered a specific microbiome signature in patients responder to immune-oncology drugs such as anti-PD1 / PDL1 and developed a new bacterial consortium.
New research indicates that the tumor-resident microbiota can promote the formation of metastases as well as the survival of cancer cells during tumor progression.
Researchers have found that a specific microbial metabolite may boost the efficacy of anticancer therapy in people with TNBC. The findings could inform the development of improved treatments for TNBC.
New research investigates the role of lung microbiota in pediatric patients with lung infection or injury after bone marrow transplantation.
The findings could help to develop microbiota-based strategies to advance immunothery treatments for melanoma.
